Additionally, few studies have shown that the beta 2 adrenergic receptor itself, either decreased production or decreased sensitization, were also discovered. A challenge to our medical community includes finding other treatments for psoriasis that would induce the expression of beta-adrenergic receptors on keratinocytes or ways to hinder this mechanism without changing our patients' drug regimens. The gene discussed is ADRB2; the disease is psoriasis.